Your email has been successfully added to our mailing list.

×
0 0 0 0 0.00303030303030297 0.00303030303030297 0.00909090909090903 0.00909090909090903
Stock impact report

Aileron Therapeutics GAAP EPS of -$0.27 misses by $0.02 [Seeking Alpha]

Aileron Therapeutics, Inc. (ALRN) 
Last aileron therapeutics, inc. earnings: 11/7 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.aileronrx.com
Company Research Source: Seeking Alpha
Cash and cash equivalents as of September 30, 2024, were $17.7 million, compared to $21.9 million as of June 30, 2024. The company expects its existing cash and cash equivalents to be sufficient to fund operations into June 2025. More on Aileron Therapeutics Seeking Alpha's Quant Rating on Aileron Therapeutics Historical earnings data for Aileron Therapeutics Financial information for Aileron Therapeutics Show less Read more
Impact Snapshot
Event Time:
ALRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ALRN alerts
Opt-in for
ALRN alerts

from News Quantified
Opt-in for
ALRN alerts

from News Quantified